---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-086124"
form_type: "8-K"
ticker: "CLIR"
cik: "0001434524"
company_name: "ClearSign Technologies Corp"
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:13:09.241220+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ClearSign appoints G. Todd Silva to board of directors effective August 1, 2024

## Summary
- Mr. Silva, nominated by clirSPV LLC, fills vacancy created by Robert T. Hoffman, Sr.'s June 2024 resignation.
- He brings over 30 years of leadership and finance experience; currently CFO of Radiance Therapeutics.
- Mr. Silva will receive quarterly RSU grants of $15,000 under the 2021 Equity Incentive Plan.
- Initial RSU grant pro-rated for the portion of Q3 2024 served on the board.
- Appointment effective August 1, 2024; no other arrangements or family relationships disclosed.

## SEC filing metadata
- accession: 0001104659-24-086124
- form_type: 8-K
- ticker: CLIR
- cik: 0001434524
- company_name: ClearSign Technologies Corp
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434524/000110465924086124/0001104659-24-086124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434524/000110465924086124/tm2420801d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-086124
- JSON: https://secwatch.observer/filing/0001104659-24-086124.json
- Plain text: https://secwatch.observer/filing/0001104659-24-086124.txt

## Key facts
- Executive change
  G. Todd Silva was appointed as Director at ClearSign Technologies Corp.
  - Action: appointed
  - Role: Director
  source text: Upon recommendation of the Governance Committee, and effective as of August 1, 2024 (the “Effective Date”), Mr. Silva was appointed to the Board as the SPV’s designee to fill the vacancy created by Mr. Hoffman’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434524/000110465924086124/0001104659-24-086124-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.